Long-term outcome in patients with pTxN+ adenocarcinoma of prostate treated with radical prostatectomy and early androgen ablation.

Seay, T M; Blute, M L; Zincke, H

Seay, T M; Blute, M L; Zincke, H.

Affiliation

Seay TM; Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA.

J Urol ; 159(2): 357-64, 1998 Feb.

Article in En | MEDLINE | ID: mdl-9649239

Subject(s)

Adenocarcinoma/surgery; Orchiectomy; Prostatectomy; Prostatic Neoplasms/surgery; Adenocarcinoma/mortality; Adenocarcinoma/pathology; Adult; Aged; Disease Progression; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Prostatic Neoplasms/mortality; Prostatic Neoplasms/pathology; Retrospective Studies; Survival Rate; Time Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatectomy / Prostatic Neoplasms / Orchiectomy / Adenocarcinoma Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Humans / Male / Middle aged Language: En Journal: J Urol Year: 1998 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links